CDC Cancels Meeting on Vaccine Induced Heart Problems For Young People to Celebrate Juneteenth
In perhaps one of their most blatantly shameless political moves yet, government employees working at the Center for Disease Control decided to postpone an emergency meeting discussing why young adults are being hospitalized for post-vaccine heart inflammation following inoculation from the COVID-19 vaccine.
June 17 (Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Thursday put off its meeting to discuss the occurrence of myocarditis among people who received COVID-19 shots due to the Juneteenth national holiday.
Advisers to CDC were set to meet on Friday to assess the possibility of a link between rare cases of heart inflammation and mRNA COVID-19 vaccines from Pfizer-BioNTech and Moderna
The discussion will be rescheduled to be included as part of its meeting from June 23-25, the CDC said. (Reporting by Amruta Khandekar; Editing by Arun Koyyur)
This comes after the World Health Organization took the position that “Children should not be vaccinated for the moment,” a statement that was scrubbed from the website entirely shortly after being posted on June 22nd.
Interestingly, the language on the just-mentioned WHO link seems to have changed quite a bit, with it now saying “Children and adolescents tend to have milder disease compared to adults, so unless they are part of a group at higher risk of severe COVID-19, it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers,” and that “More evidence is needed on the use of the different COVID-19 vaccines in children to be able to make general recommendations on vaccinating children against COVID-19.”
The WHO appeared to contradict themselves on this a moment later, seemingly encouraging vaccination for children 12 and older.
“WHO’s Strategic Advisory Group of Experts (SAGE) has concluded that the Pfizer/BionTech vaccine is suitable for use by people aged 12 years and above. Children aged between 12 and 15 who are at high risk may be offered this vaccine alongside other priority groups for vaccination. Vaccine trials for children are ongoing and WHO will update its recommendations when the evidence or epidemiological situation warrants a change in policy.”
After a 4 day delay the meeting occurred on Wednesday, with experts still insisting that they do not know whether the sudden increase in heart problems amongst young people post-vaccine was caused by the experimental shot or not.